Page last updated: 2024-11-04

sulfaphenazole and Experimental Neoplasms

sulfaphenazole has been researched along with Experimental Neoplasms in 3 studies

Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, F1
Wang, HJ1
Jin, YH1
Zhang, Q1
Wang, ZH1
Jia, JM1
Liu, F1
Wang, L1
Bao, QC1
Li, DD1
You, QD1
Xu, XL1
Vesci, L1
Milazzo, FM1
Stasi, MA1
Pace, S1
Manera, F1
Tallarico, C1
Cini, E1
Petricci, E1
Manetti, F1
De Santis, R1
Giannini, G1
Rajendran, P1
Jaggi, M1
Singh, MK1
Mukherjee, R1
Burman, AC1

Other Studies

3 other studies available for sulfaphenazole and Experimental Neoplasms

ArticleYear
Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90.
    Journal of medicinal chemistry, 2016, 12-08, Volume: 59, Issue:23

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P

2016
Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo.
    European journal of medicinal chemistry, 2018, Sep-05, Volume: 157

    Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dos

2018
Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity.
    Investigational new drugs, 2008, Volume: 26, Issue:1

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Betulinic Acid; Blood Proteins; Cell Line, Tumor;

2008